Third-party funded research projects of the Institute of Medical Statistics:
| Project | Project management | Project title | Project duration |
|---|---|---|---|
| Martin Posch | Sharing and Re-Using Clinical Trial Data to Maximise Impact | 1.1.2024–31.12.2027 | |
| Martin Posch, Franz König | Innovative Designs, Extrapolation, Simulation Methods and Evidence-Tools for Rare Diseases Addressing Regulatory Needs | 1.1.2024–31.12.2028 | |
Quality Control Measures for Biomedical Animal Studies (Bürgermeisterfond) | Florian Frommlet | Quality Control Measures for Biomedical Animal Studies | 1.5.2023–30.4.2024 |
| eWHORM – Enabling the WHO-Road Map 2030 | MUW: Bertrand Lell (lead), Sonja Zehetmayer, Martin Posch | EU project to reduce the burden of disease associated with worm infections in Sub Saharan Africa | 1.4.2023–31.3.2028 |
| IMI – EU-PEARL | Franz König, Martin Posch | EU patient-centric clinical trial platform | 1.11.2019–30.4.2023 |
| European Joint Programme on Rare Diseases (EJP RD) | Franz König, Martin Posch | Application of improved statistical methodologies for clinical trials in Progressive Supranuclear Palsy | 24 months |
| nutritionDay | Michael Hiesmayr | (nDay) study | ongoing |
| FWF (KLI 754) | Manfred Hecking | Sex Differences in Kidney Disease Identification & Treatment | 1.3.2019–28.2.2022 |
| EU – Horizon 2020 | Franz König (Deputy Coordinator, WP-Leader) | IDEAS (Improving Design, Evaluation and Analysis of early drug development Studies) | 1.1.2015–31.12.2018 |
| MRC | Gemeinsames Projekt mit Lancaster University, UK (Thomas Jaki), MedUni Wien: Martin Posch | HMT: Accuracy vs. Precision – Developing optimal estimators for trials with multiple hypothesis tests | 1.10.2014–30.9.2017 |
| EU-FP7 | Martin Posch (Leader of WP 3: Research in confirmatory trials for small populations and personalised medicines) | Inspire (Innovative methodology for small populations research) | 1.2.2014–31.5.2017 |
| EU-FP7 | Franz König (Leader of WP 4: Adaptive designs) | IDEAL (Integrated DEsign and AnaLysis of small populations) | 1.11.2013–31.10.2016 |
| EU-FP7 | Martin Posch (Leader of WP 2: New and improved methods for individual trial design) | ASTERIX (Advances in Small Trials dEsign for Regulatory Innovation and eXcellence) | 1.10.2013–30.9.2017 |
| FWF (Austrian Science Fund) and JSPS (Japan Society for the Promotion of Science) | Martin Posch | Joint Seminar "Innovative Clinical Trial Designs for Accelerating Medical Product Development" | März 2015 |
| ASDI | Philipp Metnitz | ASDI: Zertifizierung von Intensivstationen | 1.1.2011– |
| FWF Erwin Schrödinger Program Nr. J 3721 | Florian Klinglmüller | Permutation Tests for Adaptive Clinical Trials | 14.05.2015–13.05.2016 |
| FWF-Projekt P23167 | Martin Posch | Hypothesis Testing and Estimation in Adaptive Designs with Blinded and Unblinded Interim Analysis | 1.10.2010–31.10.2015 |
| WWTF-Mathematics und ... Call 2009 – MA09-007 | Florian Frommlet | Optimal Selection Procedures in Genome Wide Association Studies | 1.3.2010–31.8.2014 |
| FWF-Erwin-Schrödinger-Stipendium Nr. J3344-N26 | Alexandra Graf | Type 1 Error Rate Inflation in Multi-Armed Clinical Trials | 1.12.2012–30.11.2013 |
| FWF-Hertha-Firnberg-Programm T-401 | Sonja Zehetmayer | Wiederholte Signifikanztests bei Kontrolle der False Discovery Rate | 1.6.2009–31.10.2012 |
| FWF-Projekt P21763 | Werner Brannath | Computational Methods for Adaptive and Multiple Inference | November 2009 bis Oktober 2012 |
| British Council | AT: Martin Posch & Franz König | Academic Research Collaboration „Optimal Adaptive Trials with Treatment Selection“ | 2007 |
| FWF-Projekt P18698-N15 | Peter Bauer | Adaptive Designs – Evaluation and New Applications | Mai 2006 bis Oktober 2009 |
| FWF-Projekt P15853-N04 | Peter Bauer | Evaluation of Adaptive Design Procedures | Mai 2003 bis April 2006 |
| FWF-Erwin-Schrödinger-Stipendium J2065 | Werner Brannath | Resampling bei Konfidenzintervallen für adaptive Designs | 1.9.2001–31.10.2002 |